|
|
EAU 2011 - Nephrectomy improves overall survival in patients with metastatic ... - UroToday |
UroToday
VIENNA, AUSTRIA (UroToday.com) - Cytoreductive nephrectomy should be performed in patients with metastatic kidney cancer who are fit enough for surgery. The authors analyzed 351 patients with metastatic kidney cancer for a possible impact of
|
|
|
Home dialysis business NxStage rewards top executives with pay bumps - MedCity News |
MedCity News
NxStage Medical Inc. (NASDAQ:NXTM) handed out pay raises to several members of its leadership team after a year that saw the dialysis maker boost sales 20 percent and cut its net losses. The Lawrence, Mass.-based company rewarded CEO Jeffrey Burbank
|
|
Early Steroid Withdrawal Cuts CV Event Rates in Transplant Recipients - Renal and Urology News |
Renal and Urology News
She and her colleagues analyzed prospective CV event data from 1004 renal transplant recipients, of whom 714 received ECSWD (with corticosteroids withdrawn within seven days after transplantation) and 290 received chronic corticosteroid (CCS)
|
|
ECG Findings May Identify Transplant Candidates at Higher Death Risk - Renal and Urology News |
Renal and Urology News
PHILADELPHIA—Abnormalities revealed by electrocardiography (ECG) may predict which patients undergoing evaluation for a renal transplant are at higher risk of death, a study found. These abnormalities include prolonged PR or QTc intervals.
|
|
Delayed Graft Function Risk Not Lowered with High-Dose EPO - Renal and Urology News |
Renal and Urology News
The double-blind, placebo-controlled study, by a team at Leiden University Medical Center in Leiden, The Netherlands, included 92 renal transplant recipients who received organs from non-heart-beating donors. Those assigned to the EPO group received
|
|
|
|
|
<< Start < Prev 931 932 933 934 935 936 937 938 939 940 Next > End >>
|
|
Page 934 of 2630 |